Premier Alternatives

OncoNano Medicine

Dallas, TX · Founded 2014 · Privately Held (backing)

Developer of a nanotechnology platform designed to improve the delivery and activation of cancer therapies in acidic tumor environments. OncoNano Medicine is based in Dallas, TX and was founded in 2014. It was valued at $60 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $117 million across 3 recorded rounds; the latest was a $12.7 million early-stage round in Apr 2025.

PMV mark · valuation
$60.0M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$116.5M
Last round
Early Stage VC
Apr 2025

OncoNano Medicine key facts

as of Oct 2026
  • Developer of a nanotechnology platform designed to improve the delivery and activation of cancer therapies in acidic tumor environments.
  • OncoNano Medicine is valued at approximately $60.0M as of Oct 2026, set at its later-stage round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $116.5M across 3 recorded rounds; the latest was Early Stage VC ($12.7M) in Apr 2025.
  • Notable investors include National Institutes of Health, AG Collective Capital, Advantech Capital Partners, CKG Management, Cancer Prevention and Research Institute of Texas — 9 tracked in total.
  • OncoNano Medicine has filed 7 Form Ds with the SEC since 2018, most recently Jun 2025 ($12.7M sold to 25 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$60.0M

Valued at $60.0M at its later-stage round, Jun 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of OncoNano Medicine with a free account
  • ·Watch OncoNano Medicine: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

OncoNano Medicine funding rounds

3 rounds
Apr 2025Early Stage VC$12.7MSEC filing▮
Oct 2020Later Stage VC$68.4MSEC filing▮
Mar 2018Early Stage VC$33.9MSEC filing▮
Full funding history →

OncoNano Medicine valuation

OncoNano Medicine was valued at $60 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has OncoNano Medicine raised?

OncoNano Medicine has raised $117 million across 3 recorded rounds since 2018. The largest was a $68.4 million later-stage round in Oct 2020; the most recent was a $12.7 million early-stage round in Apr 2025.

OncoNano Medicine has filed 7 Form Ds with the SEC since 2018, most recently in Jun 2025 ($12.7 million sold to 25 investors).

OncoNano Medicine investors

9 investors are on record for OncoNano Medicine, including National Institutes of Health, AG Collective Capital, Advantech Capital Partners and CKG Management. The early-stage round in Apr 2025 drew 25 investors.

About OncoNano Medicine

Developer of a nanotechnology platform designed to improve the delivery and activation of cancer therapies in acidic tumor environments. The company offers an ultra pH-sensitive polymeric micelle system, which remains inactive in the bloodstream, helping surgeons to treat advanced cancer patients to access safer and more effective treatment options with reduced side effects.

Sector
Healthcare
HQ
Dallas, TX, United States
Founded
2014
Employees
23
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.